Outbreaks of meningococcal B infection and the 4CMenB vaccine: historical and future perspectives

Neisseria Adhesin A Variation and Revised Nomenclature Scheme

(2014) Stefania Bambini et al.   Clinical and Vaccine Immunology

Implications of Differential Age Distribution of Disease-Associated Meningococcal Lineages for Vaccine Development

(2014) Carina Brehony et al.   Clinical and Vaccine Immunology

Prolonged University Outbreak of Meningococcal Disease Associated With a Serogroup B Strain Rarely Seen in the United States

(2013) Sema Mandal et al.   CLINICAL INFECTIOUS DISEASES

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

(2013) Timo Vesikari et al.   LANCET

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment

(2013) Ulrich Vogel et al.   LANCET INFECTIOUS DISEASES

Phenotypic and Genotypic Characteristics of Neisseria meningitidis Disease-Causing Strains in Argentina, 2010

(2013) Cecilia Sorhouet-Pereira et al.   PLoS One

An Analysis of the Sequence Variability of Meningococcal fHbp, NadA and NHBA over a 50-Year Period in the Netherlands

(2013) Stefania Bambini et al.   PLoS One

Molecular Characterization of Invasive Neisseria meningitidis Strains Isolated in Chile during 2010–2011

(2013) Gisselle N. Barra et al.   PLoS One

Geotemporal Analysis of Neisseria meningitidis Clones in the United States: 2000–2005

(2013) Ann E. Wiringa et al.   PLoS One

Persistence of antibodies in adolescents 18−24 months after immunization with one, two, or three doses of 4CMenB meningococcal serogroup B vaccine

(2013) Maria Elena Santolaya et al.   Human Vaccines & Immunotherapeutics

Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future

(2013) Johan Holst et al.   Human Vaccines & Immunotherapeutics

Microbiological epidemiological history of meningococcal disease in Rio de Janeiro, Brazil

(2012) David Eduardo Barroso et al.   Brazilian Journal of Infectious Diseases

Developing vaccines in the era of genomics: a decade of reverse vaccinology

(2012) K.L. Seib et al.   CLINICAL MICROBIOLOGY AND INFECTION

Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization Schedules

(2012) Nicoletta Gossger et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Invasive Serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: Persistence of the ST-269 Clone Since It First Emerged in 2003

(2012) J. Zhou et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study

(2012) María Elena Santolaya et al.   LANCET

The Disease Burden of Invasive Meningococcal Serogroup B Disease in Canada

(2012) Julie A. Bettinger et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Molecular Epidemiology of Neisseria meningitidis Serogroup B in Brazil

(2012) Ivano de Filippis et al.   PLoS One

Persistence of Hyperinvasive Meningococcal Strain Types during Global Spread as Recorded in the PubMLST Database

(2012) Eleanor R. Watkins et al.   PLoS One

The Changing Epidemiology of Meningococcal Disease in Quebec, Canada, 1991–2011: Potential Implications of Emergence of New Strains

(2012) Rodica Gilca et al.   PLoS One

Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac

(2012) François Caron et al.   VACCINE

The challenge of post-implementation surveillance for novel meningococcal vaccines

(2012) Matthew D. Snape et al.   VACCINE

Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?

(2012) Eva Hong et al.   VACCINE

Development of a Multiplex PCR Assay for Detection and Genogrouping of Neisseria meningitidis

(2011) Hongfei Zhu et al.   JOURNAL OF CLINICAL MICROBIOLOGY

From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak

(2011) François Caron et al.   LANCET INFECTIOUS DISEASES

Detection of a geographical and endemic cluster of hyper-invasive meningococcal strains

(2011) Sophie Bertrand et al.   MICROBES AND INFECTION

Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand

(2011) Richard Arnold et al.   VACCINE

Immunogenicity and Safety of a Multicomponent Meningococcal Serogroup B Vaccine and a Quadrivalent Meningococcal CRM197Conjugate Vaccine against Serogroups A, C, W-135, and Y in Adults Who Are at Increased Risk for Occupational Exposure to Meningococcal Isolates

(2010) Alan Kimura et al.   Clinical and Vaccine Immunology

Epidemiological Profile of Meningococcal Disease in the United States

(2010) Lee H. Harrison   CLINICAL INFECTIOUS DISEASES

The epidemiology of meningococcal disease and the impact of vaccines

(2010) Ameneh Khatami et al.   Expert Review of Vaccines

Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis

(2010) Karen Edmond et al.   LANCET INFECTIOUS DISEASES

Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing

(2010) L. F. Baethgen et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease

(2009) Amanda C. Cohn et al.   CLINICAL INFECTIOUS DISEASES

Morbidity, mortality and spatial distribution of meningococcal disease, 1974–2007

(2009) M. HOWITZ et al.   EPIDEMIOLOGY AND INFECTION

Clonal Distribution of Disease-Associated and Healthy Carrier Isolates ofNeisseria meningitidisbetween 1983 and 2005 in Cuba

(2009) Yanet Climent et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Characterization of fHbp, nhba (gna2132), nadA, porA, Sequence Type (ST), and Genomic Presence of IS1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and Wales

(2009) J. Lucidarme et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Immunogenicity and Tolerability in Infants of a New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine

(2009) Sharon H. Wong et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Meningococcal carriage and disease—Population biology and evolution

(2009) Dominique A. Caugant et al.   VACCINE

Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus

(2009) Stefania Bambini et al.   VACCINE

Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease

(2009) Susanne Jacobsson et al.   VACCINE

Global epidemiology of meningococcal disease

(2009) Lee H. Harrison et al.   VACCINE

Hyperinvasive genotypes of Neisseria meningitidis in France

(2008) M.L. Zarantonelli et al.   CLINICAL MICROBIOLOGY AND INFECTION

Genetics and evolution of Neisseria meningitidis: Importance for the epidemiology of meningococcal disease

(2008) Dominique A. Caugant   INFECTION GENETICS AND EVOLUTION

Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years

(2008) Y. Galloway et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY